Due to the fact that the testing of the germinal line of all the patients suspect of Lynch syndrome is very expensive, a sequential genetic evaluation, which starts with PCR tumor testing for MSI (MSI-H = positive test) and/ or by immunohistochemistry for the MMR genes expression (loss of the proteins color = positive test), should be undergone [10]. The gene discussed is MRC1; the disease is Lynch syndrome.